- Home
- DDD vs TARA Comparison
DDD vs TARA Comparison
Compare DDD & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDD | TARA |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.8M | 268.5M |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DDD | TARA |
|---|---|---|
| Price | $2.04 | $6.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.75 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 2.0M | 966.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 30.47 | ★ 39.22 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $440,121,000.00 | $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.31 | N/A |
| P/E Ratio | $7.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.48 | $2.77 |
| 52 Week High | $3.80 | $7.82 |
Technical Indicators
Market Signals| Indicator | DDD | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 49.58 |
| Support Level | $1.95 | $6.23 |
| Resistance Level | $2.23 | $7.58 |
| Average True Range (ATR) | 0.12 | 0.54 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 37.21 | 45.00 |
Price Performance
Historical ComparisonAbout DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).